Partnerships: boosting efficacy & accelerating progress
At Domain, our purpose is to unlock the power of the immune system by delving into science that has the potential to set the direction for identifying future biomedical treatments to improve people’s lives.
At our core, we value and target partnerships that push scientific boundaries and address rare unmet medical needs. We work closely with the best, pioneers in the industry from top pharmaceutical and biotech companies, uniting external experts to create synergy that fuels innovation and fulfils our shared vision.
Our research benefits from an external network of academic and industry alliances focussed on areas of mutual scientific interest. We facilitate access to ideas and knowledge to tackle longstanding research challenges, advancing our GPCR based drug discovery assets to the clinic.
Working together, we can build success through innovation, broadening the scientific scope.
Collaborations
GPCR target for metabolic diseases
Precision Medicine and Immunotherapy of Sarcoma
Multi-target collaboration for rare diseases
